Table I.
in vivo immune responses | Role of PKCθ | Immune cells implicated in response |
References |
---|---|---|---|
Effector function/memory responses/ viral clearance upon LCMV infection | Dispensable | CTL, Th1 | Berg-Brown et al., 2004 |
Neutralizing antibodies against VSV infection | Dispensable | B cells, Tfh help | Berg-Brown et al., 2004 |
Murine herpes virus-68 clearance, expansion of virus-specific CD8+ T cells | Dispensable | CTL | Giannoni et al., 2005 |
Recall responses to vaccinia virus infection | Dispensable | CTL | Marsland et al., 2005 |
Murine CMV clearance, expansion of virus-specific CD8+ T cells | Dispensable | CTL | Valenzuela et al., 2009 |
Effector CTL response to Listeria Monocytogenes (LM) infection1 | Dispensable | CTL | Valenzuela et al., 2009 |
LM clearance, effector cell expansion2 | Required | CTL, Th1 | Sakowicz-Burkiewicz et al., 2008 |
Effector response against T. gondii infection, pathogen clearance | Required | Th1, CTL, Th2, B cells | Nishanth et al., 2010 |
Plasmodium berghei ANKA-induced Inflammatory cerebral malaria | Moderately required | Th1, CTL? | Ohayon et al., 2010 |
Leishmenia major clearance, effector response against infection | Dispensable (B6) | Th1 | Marsland et al., 2004 |
Required (Balb/C) | Th2 | ||
Immunity to M-MuLV-induced leukemia | Required | CTL, Th1 | Garaude et al., 2008 |
Rejection of engrafted MHC class I-negative tumors | Required | NK | Aguilo et al., 2009 |
Lung inflammation induced by ovalbumin administration | Dispensable | Th13 | Salek-Ardakani et al., 2004; Marsland et al. 2004 |
Required | Th24 | ||
IgE, eosinophilia response to N. Brasiliensis infection | Required | Th2 | Marsland et al., 2004 |
GvL response | Dispensable | Th1, CTL? | Valenzuela et al., 2009 |
Systemic GvHD | Required | Th1, CTL | Valenzuela et al., 2009 |
Local (footpad) host vs. graft response | Required | Th1, CTL | Anderson et al., 2006 |
Early (1–3 hr) cytokine response to anti-CD3 injection | Required | NKT? | Anderson et al., 2006 |
Cardiac allograft rejection | Mildly required; cooperates with PKCα | Th1, CTL | Gruber et al., 2009 |
Required | Manicassamy et al., 2008 | ||
Coxsackie B3-induced autoimmune myocarditis | Dispensable | Th1 | Marsland et al., 2007 |
α-myosin/CFA-induced experimental autoimmune myocarditis | Required | Th17 | Marsland et al., 2007 |
Autoimmune colitis, EAE | Required | Th17, Th1 | Anderson et al., 2006; Salek-Ardakani et al., 2005;Tan et al., 2006 |
Methylated BSA-induced arthritis | Required | Th1, Th2, B cells | Healy et al., 2006 |
Concanavalin A-induced autoimmune hepatitis | Required | NKT | Fang et al., 2012 |
2×103 CFU LM-Ova
5×104 CFU LM-Ova
Ova/CFA immunization s.c.
Ova/alum immunization i.p.